Logo CICANCER
Intranet Colaborate

Old CIC Events

Connecting myeloid cell metabolism and function 02/03/2023

Connecting myeloid cell metabolism and function

David Sancho Madrid — Centro Nacional de Investigaciones Cardiovasculares de Madrid

AHR adjusts senescence and stemness: impact in tissue regeneration and tumor progression 23/02/2023

AHR adjusts senescence and stemness: impact in tissue regeneration and tumor progression

Pedro M. Fernández Salguero — Universidad de Extremadura, Badajoz.

ctDNA in cancer care 16/02/2023

ctDNA in cancer care

Elza de Bruin — Director Translational Medicine, AstraZeneca, Cambridge, UK

Metabolic Reprogramming in Cancer Progression: Making the difference 09/02/2023

Metabolic Reprogramming in Cancer Progression: Making the difference

Patricia Altea Manzano — Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Belgium

Spatial synthetic lethality- a new approach to treat B cell lymphoma (?) 03/02/2023

Spatial synthetic lethality- a new approach to treat B cell lymphoma (?)

Ingo Ringshausen — University of Cambridge, Wellcome–MRC Cambridge Stem Cell Institute

Self-organization of MAPK Signaling Dynamics in the Epithelium 02/02/2023

Self-organization of MAPK Signaling Dynamics in the Epithelium

Olivier Pertz — Institute of Cell Biology, University of Bern (Swizerland)

Cell-of-origin as a route to understand the onset of aggressive prostate tumours 01/02/2023

Cell-of-origin as a route to understand the onset of aggressive prostate tumours

Esther Baena — Cancer Research UK Manchester Institute, University of Manchester

Defensa de tesis doctoral: Guanosine-7 tRNA methylation regulates Prostate Cancer progression through protein reprogramming via tRNA-derived fragments biogenesis 27/01/2023

Defensa de tesis doctoral: Guanosine-7 tRNA methylation regulates Prostate Cancer progression through protein reprogramming via tRNA-derived fragments biogenesis

Raquel García-Vílchez — Programa de doctorado Biociencias: Biología y Clínica del Cáncer y Medicina Traslacional

VAV1 mutations act as cancer drivers in T cell lymphomas 26/01/2023

VAV1 mutations act as cancer drivers in T cell lymphomas

Javier Robles Valero — Centro de Investigación del Cáncer (CIC-IBMCC), Salamanca.

Unexpected noncoding RNA roles in the regulation of the cancer genome 19/01/2023

Unexpected noncoding RNA roles in the regulation of the cancer genome

Maite Huarte — CIMA, University of Navarra

A new approach to old problems: epitranscriptomics in aging and rejuvenation 12/01/2023

A new approach to old problems: epitranscriptomics in aging and rejuvenation

Diana Guallar — Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela

Emerging biomarkers for precision cancer medicine: Discovery, validation and clinical application 15/12/2022

Emerging biomarkers for precision cancer medicine: Discovery, validation and clinical application

Dr. Jian-Hua Mao — Lawrence Berkeley National Laboratory / University of California [Berkeley, USA]